Sponsor Pipeline

Yancheng First People's Hospital Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07155265 REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable… Critical Illness; Mechanical Ventilation; Shock Not Yet Recruiting
Phase 2
NCT05522582 Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors Solid Tumors Active, Not Recruiting
Get alerts when Yancheng First People's Hospital's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free